NCT01005056View on ClinicalTrials.gov

Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)

CompletedOBSERVATIONAL
Enrollment

3,838

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Contraception
Interventions
DRUG

Ethinylestradiol + Desogestrel

All participants receive Marvelon® according to the approved dosage and administration method.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01005056 - Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083) | Biotech Hunter | Biotech Hunter